Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): A review of the literature and a practical approach to therapy

Keyphrases

• Muscle-invasive Bladder Cancer 100%
• Bladder Preservation 100%
• Radical Cystectomy 57%
• Bladder-sparing 57%
• High Risk 28%
• Chemoradiotherapy 28%
• Medical Comorbidity 28%
• Limited Disease 28%
• Transurethral Resection 28%
• Radical Surgery 28%
• Inoperable Patients 28%
• Unfit for Surgery 28%
• Trimodal 28%
• Preservation Approaches 28%
• Treatment Options 14%
• Bladder 14%
• Urologists 14%
• Long-term Complications 14%
• Complete Response 14%
• Therapeutic Potential 14%
• Medically Inoperable 14%
• Patient Selection 14%
• Decision Tree 14%
• Response to Treatment 14%
• Perioperative Period 14%
• Combined Modality Therapy 14%
• Aggressive Surgery 14%
• Urinary Diversion 14%
• Long-term Morbidity 14%
• Pathological Parameters 14%
• Multimodal Approach 14%
• Medically Operable 14%

Medicine and Dentistry

• Bladder 100%
• Muscle Invasive Treatment of Bladder Cancer 100%
• Muscle Invasive Bladder Cancer 62%
• Cystectomy 50%
• Diseases 37%
• Chemoradiotherapy 25%
• Transurethral Resection 25%
• Radical Surgery 25%
• Bladder Surgery 25%
• Comorbidity 25%
• Urologist 12%
• Perioperative Period 12%
• Urinary Diversion 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Muscle Invasive Bladder Cancer 100%
• Diseases 42%
• Chemoradiation Therapy 28%
• Comorbidity 28%